Volunteers are the heart of Rally's mission!
Dr. Velasquez is interested in adoptive immunotherapy of hematological malignancies. Her current work is focused on using genetically modified T cells to target hematological malignancies, their functional characterization in vitro, and working with leukemia and lymphoma xenograft models.
Dr. Velasquez received her MD from the Universidad Francisco Marroquin in Guatemala followed by her training at Baylor College of Medicine.